Hone DM - Search Results

1

Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.

Hone DM, DeVico AL, Fouts TR, Onyabe DY, Agwale SM, Wambebe CO, Blattner WA, Gallo RC, Lewis GK. Hone DM, et al. J Hum Virol. 2002 Jan-Feb;5(1):17-23. J Hum Virol. 2002. PMID: 12352264 Review.

2

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

Devico AL, Fouts TR, Shata MT, Kamin-Lewis R, Lewis GK, Hone DM. Devico AL, et al. Among authors: hone dm. Vaccine. 2002 May 6;20(15):1968-74. doi: 10.1016/s0264-410x(02)00080-4. Vaccine. 2002. PMID: 11983256 Review.

3

Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine.

Fouts TR, Lewis GK, Hone DM. Fouts TR, et al. Among authors: hone dm. Vaccine. 1995 Apr;13(6):561-9. doi: 10.1016/0264-410x(94)00016-g. Vaccine. 1995. PMID: 7483777

4

A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.

Agwale SM, Shata MT, Reitz MS Jr, Kalyanaraman VS, Gallo RC, Popovic M, Hone DM. Agwale SM, et al. Among authors: hone dm. Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10037-41. doi: 10.1073/pnas.152313899. Epub 2002 Jul 2. Proc Natl Acad Sci U S A. 2002. PMID: 12096189 Free PMC article.

5

Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin.

Bagley KC, Shata MT, Onyabe DY, DeVico AL, Fouts TR, Lewis GK, Hone DM. Bagley KC, et al. Among authors: hone dm. Vaccine. 2003 Jul 4;21(23):3335-41. doi: 10.1016/s0264-410x(03)00038-0. Vaccine. 2003. PMID: 12804865

6

Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1.

Fouts TR, DeVico AL, Onyabe DY, Shata MT, Bagley KC, Lewis GK, Hone DM. Fouts TR, et al. Among authors: hone dm. FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):129-34. doi: 10.1016/S0928-8244(03)00067-1. FEMS Immunol Med Microbiol. 2003. PMID: 12832116 Free article. Review.

7

Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.

Fouts TR, Tuskan R, Godfrey K, Reitz M, Hone D, Lewis GK, DeVico AL. Fouts TR, et al. J Virol. 2000 Dec;74(24):11427-36. doi: 10.1128/jvi.74.24.11427-11436.2000. J Virol. 2000. PMID: 11090138 Free PMC article.

8

Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine.

Hone DM, Lewis GK, Beier M, Harris A, McDaniels T, Fouts TR. Hone DM, et al. Dev Biol Stand. 1994;82:159-62. Dev Biol Stand. 1994. PMID: 7958470 Review.

9

Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses.

Hone DM, Wu S, Powell RJ, Pascual DW, Van Cott J, McGhee J, Fouts TR, Tuskan RG, Lewis GK. Hone DM, et al. J Biotechnol. 1996 Jan 26;44(1-3):203-7. doi: 10.1016/0168-1656(95)00151-4. J Biotechnol. 1996. PMID: 8717405 Review.

10

Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120.

Fouts TR, Tuskan RG, Chada S, Hone DM, Lewis GK. Fouts TR, et al. Among authors: hone dm. Vaccine. 1995 Dec;13(17):1697-705. doi: 10.1016/0264-410x(95)00106-b. Vaccine. 1995. PMID: 8719522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters